ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

12 links4 made here, not in the record13 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule basedMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06463665Efficacy & Safety ofOlvimulogene Nanivacirepvec& Platinum-doublet +Physician's Choice ofImmune Checkpoint InhibitorCompared to Docetaxel inNSCL CancerGenelux CorporationPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSCarcinoma, Non-Small-Cell L…The registry's MeSH filing›Nov 14 · Rule based · Finest filed termAs of now · Rule based · Main conditionMain conditionVacciniaThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termNeoplasms by SiteThe registry's MeSH filing›Nov 14 · Rule based · Wider: a narrower term is filedWider: a narrower term is filedNeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseCarcinomaThe registry's MeSH filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseNeoplasms by Histologic TypeThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termDRUGSOlvimulogene nanivacirepvecIntervention entry›Nov 18 · Rule based · TestedTestedDocetaxelIntervention entry›Nov 18 · Rule based · ComparatorComparatorPembrolizumabMade here · Found by reading; no entr…›Nov 1 · Claude Opus 5.5 · BackgroundBackgroundNivolumabMade here · Found by reading; no entr…›Nov 2 · Claude Opus 5.5 · BackgroundBackgroundDurvalumabMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · BackgroundBackgroundAtezolizumabMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · Background · partnerBackground · partner

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Pembrolizumab

Made here1 judgment on this link
NCT06463665gives it, found by reading the recordPembrolizumabDefined by Claude Opus 5.5Nov 1, 2026, 8:22 AM UTC
Role in the study, from the registry to what was judged
RegistryNot in the recordno intervention entry names it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Nov 1Pembrolizumabmade hereClaude Opus 5.5BackgroundCurrent
Nov 2Nivolumabmade hereClaude Opus 5.5BackgroundCurrent
Nov 3Durvalumabmade hereClaude Opus 5.5BackgroundCurrent
Nov 3Atezolizumabmade hereClaude Opus 5.5Background · partnerCurrent
Nov 14Carcinoma, Non-Small-Cell LungRule based · condition-kind ruleFinest filed termCurrent
Nov 14VacciniaRule based · condition-kind ruleFinest filed termCurrent
Nov 14Neoplasms by SiteRule based · condition-kind ruleWider: a narrower term is filedCurrent
Nov 14NeoplasmsRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14CarcinomaRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14Neoplasms by Histologic TypeRule based · condition-kind ruleFinest filed termCurrent
Nov 18Olvimulogene nanivacirepvecRule based · role ruleTestedCurrent
Nov 18DocetaxelRule based · role ruleComparatorCurrent
As of nowCarcinoma, Non-Small-Cell LungRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.